Log in to save activitiesYour saved activities will show here so that you can easily access them whenever you're ready. Log in hereCME & EducationLog in to keep track of your credits.
Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
About This Series
Approximately 40% of patients with diabetes will develop chronic kidney disease, increasing their risk of cardiovascular disease and mortality. In Season 2 of this series, Charles Vega, MD visits with George Bakris, MD, and Matt Weir, MD to explore the effect of newer strategies and therapies approved to reduce the progression of chronic kidney disease in type 2 diabetes and decrease cardiorenal risk.
Approximately 40% of patients with diabetes will develop chronic kidney disease, increasing their risk of cardiovascular disease and mortality. In Season 2 of this series, Charles Vega, MD visits with George Bakris, MD, and Matt Weir, MD to explore the effect of newer strategies and therapies approved to reduce the progression of chronic kidney disease in type 2 diabetes and decrease cardiorenal risk.
Host
Charles P. Vega, MD
Clinical Professor, Family Medicine
University of California Irvine
Irvine, California
Season 2 Faculty
George Bakris, MD
Professor of Medicine
Director, American Heart Association Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, Illinois
Matthew R. Weir, MD
Professor of Medicine
Chief of Nephrology Division
Department of Medicine
University of Maryland School of Medicine
Baltimore, Maryland
Host
Susan J. Mayor, PhD
Medical Journalist
London, United Kingdom
Season 1 Faculty
Janet B. McGill, MD
Professor of Medicine
Division of Endocrinology, Metabolism and Lipid Research
Washington University School of Medicine
St Louis, Missouri
George L. Bakris, MD
Professor of Medicine Director, American Heart Association Comprehensive Hypertension Center University of Chicago Medicine Chicago, Illinois
Rajiv Agarwal, MD
Professor of Medicine Indiana University Indianapolis, Indiana
Peter Rossing, MD, DMSc
Professor
Department of Clinical Medicine
University of Copenhagen
Head of Complications Research
Steno Diabetes Center Copenhagen
Gentofte, Denmark
